Expeditors Form 4: Director Mark Emmert sells 4,100 shares at market prices
Rhea-AI Filing Summary
Insider sale by director Mark A. Emmert: On 08/19/2025 Mark A. Emmert, a director of Expeditors International of Washington, Inc. (EXPD), sold 4,100 shares of Expeditors common stock in multiple transactions at a weighted average price of $121.256 per share (individual prices ranged from $121.18 to $121.33). After the sale he beneficially owned 11,868 shares, held directly. The filing includes an undertaking to provide detailed per-trade quantities on request. The Form 4 was signed via attorney-in-fact Diane Heffner on 08/20/2025.
Positive
- Transparency maintained: Form 4 reports specific share counts, weighted average sale price, and offers to provide per-trade details on request.
- Director retains meaningful stake: Post-sale beneficial ownership of 11,868 shares remains, indicating continued alignment with shareholders.
Negative
- Insider sale occurred: Director disposed of 4,100 shares, which is a material reduction in his reported direct holdings.
- No plan disclosure: The filing does not indicate that the sale was made under a Rule 10b5-1 trading plan, so timing appears discretionary.
Insights
TL;DR: A board director executed a routine sale reducing direct holdings by 4,100 shares at market prices.
The transaction appears to be a straightforward open-market sale by a director rather than an option exercise or derivative disposition. The filing states the sale was executed in multiple trades with a weighted average price of $121.256, and the director retains 11,868 shares post-transaction. From a governance perspective, this is a common liquidity event for insiders and not, by itself, evidence of company-specific adverse information. The filing includes the standard undertaking to disclose per-trade quantities upon request, which supports transparency.
TL;DR: Insider sold ~25.7% of reported pre-sale direct holdings, signaling routine portfolio rebalancing.
Based solely on reported numbers, 4,100 shares were disposed leaving 11,868 shares; if those figures reflect the director's total pre-sale position, the sale reduced direct holdings materially in percentage terms. The sale occurred at prices between $121.18 and $121.33, indicating execution at prevailing market levels. No derivatives or other transactions were reported. This is a discrete disclosure event with limited standalone market implication unless accompanied by additional information.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,100 | $121.256 | $497K |
Footnotes (1)
- F1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.18 to $121.33, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated.
AI-generated analysis. How Rhea-AI works. Not financial advice.
